Company / Gross Profit
NovoCure Ltd Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$488.5M
FY2025
5-year range
$381.1M / $488.5M
FY2021-FY2025
Trend
+4.4%
vs FY2024
Sector context
#57 of 95
Health Care
What the data says
At $488M, NovoCure Ltd's gross profit ranks #57 of 95 in the Health Care sector. Improved from $381M to $488M over the past 2 years.
Based on SEC 10-K filings.
$488M in FY2025 with a 5-year CAGR of +4.7%.
Improved from $381M to $488M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +4.9%
- 5-Year CAGR
- +4.7%
- 10-Year CAGR
- -
Sector benchmark
#57 of 95 in Health CareTop 60% of 95This company $488.5M Sector average $2.0B
▼
-75.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.7%, indicating consistent growth.
- In FY2025, gross profit increased 4.4% year-over-year.
- Ranks #57 out of 95 companies in the Health Care sector.
- Lowest gross profit in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $488.5M | +4.4% |
| FY2024 | $468.0M | +22.8% |
| FY2023 | $381.1M | -9.9% |
| FY2022 | $423.0M | +0.7% |
| FY2021 | $420.2M | +8.3% |
| FY2020 | $387.9M | +47.6% |
| FY2019 | $262.7M | +56.4% |
| FY2018 | $168.0M | +38.4% |
| FY2017 | $121.4M | +231.7% |
| FY2016 | $36.6M | +193.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026